Clear Cell Adenocarcinoma (Vaginal)
Overview
Plain-Language Overview
Clear Cell Adenocarcinoma (Vaginal) is a rare type of cancer that affects the vaginal tissue, which is part of the female reproductive system. This cancer arises from abnormal growth of cells that have a clear appearance under the microscope. It mainly impacts the vaginal lining, potentially causing symptoms like abnormal bleeding or a mass. The disease can interfere with normal vaginal function and may spread to nearby organs if untreated. Early detection is important because it can affect a woman’s overall health and quality of life. This cancer is often linked to exposure to certain chemicals before birth, making it a unique condition among vaginal cancers.
Clinical Definition
Clear Cell Adenocarcinoma (Vaginal) is a malignant neoplasm characterized by the proliferation of clear cells with abundant cytoplasm and distinct cell borders, typically arising in the vaginal epithelium. It is strongly associated with in utero exposure to diethylstilbestrol (DES), a synthetic estrogen previously prescribed to pregnant women. This tumor represents a subtype of vaginal adenocarcinoma and is notable for its aggressive behavior and potential for local invasion and distant metastasis. Histologically, it shows tubulocystic, papillary, or solid growth patterns with clear cytoplasm due to glycogen content. Clinically, it presents with symptoms such as vaginal bleeding, discharge, or a palpable mass. The diagnosis is significant because it requires distinct management from other vaginal malignancies and has implications for prognosis.